|
|||||
|
|
Why published studies of the cost-effectiveness of PCSK-9 inhibitors yielded such markedly different results |
|
| Authors: | Peter P Toth Warren Stevens |
| Institution: | 1. CGH Medical Center, Sterling, IL, USA;2. Ciccarone Center for the Prevention of Heart Disease, John Hopkins University School of Medicine, Lutherville, MD, USA;3. Precision Health Economics, Los Angeles, CA, USA |
| Abstract: | |
| Keywords: | |